The China question, FDA leadership shakeups, and other biotech news from The Readout
Alastair Grant/AP
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today we’re bringing you a special report: a fascinating look at how China’s growing role in global drug development is deeply dividing the U.S. biotech industry, with executives openly debating whether reliance on Chinese partners is a competitive necessity or a national security risk.
Meanwhile, the FDA’s leadership shakeup has widened, with both CBER and CDER getting new acting directors, among other changes.
